• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

10 months ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Options Data Reflects Consistent Risk Assessment Among Traders

chest

The BTC options delta skew has remained stable, indicating that professional traders have not significantly altered their risk perceptions.

user avatarRajesh Kumar

Stable Perpetual Futures Funding Rate Indicates Healthy Market

chest

The perpetual futures funding rate for Bitcoin has remained stable, reflecting balanced trader behavior and healthy market conditions.

user avatarGustavo Mendoza

Cash App to Support USDC on Solana for Stablecoin Transfers

chest

Cash App will initially support USDC on the Solana network for stablecoin transactions.

user avatarLuis Flores

Cash App's Stablecoin Integration Part of Block's Crypto Expansion

chest

The stablecoin integration is part of Block's new product wave, enhancing Bitcoin payment tools while maintaining a Bitcoin-first philosophy.

user avatarMiguel Rodriguez

Cash App to Launch Stablecoin Functionality in Early 2026

chest

Cash App is set to introduce stablecoin send and receive features in early 2026, enhancing its blockchain capabilities.

user avatarArif Mukhtar

Economic Anxiety and Financial Independence Among Young People

chest

A significant portion of young people experience economic anxiety, impacting their financial independence goals.

user avatarMaria Gutierrez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.